InnovAge Holding Corp(INNV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.02 | Insider Own | 76.61% | Shs Outstand | 136.0M | Perf Week | -3.77% |
| Market Cap | 1.25B | Forward P/E | 18.4 | EPS next Y | 13.42% | Insider Trans | -19% | Shs Float | 31.9M | Perf Month | 4.43% |
| Enterprise Value | 1.23B | PEG | - | EPS next Q | 0.09 | Inst Own | 13.69% | Short Float | 3.59% | Perf Quarter | -18.17% |
| Income | -0.00B | P/S | 1.27 | EPS this Y | 2301.71% | Inst Trans | 2.12% | Short Ratio | 2.23 | Perf Half Y | 10.46% |
| Sales | 0.99B | P/B | 5.31 | EPS next 5Y | - | ROA | -0.44% | Short Interest | 1.15M | Perf YTD | 77.07% |
| Book/sh | 1.73 | P/C | 8.87 | EPS past 3/5Y | 60.35% 43.49% | ROE | -1.08% | 52W High | -27.29% ($12.64) | Perf Year | 99.35% |
| Cash/sh | 1.04 | P/FCF | 24.88 | Sales past 3/5Y | 12.88% 9.19% | ROIC | -0.82% | 52W Low | 133.55% ($3.93) | Perf 3Y | 70.5% |
| Dividend Est. | - | EV/EBITDA | 14.1 | EPS Y/Y TTM | 91.65% | Gross Margin | 20.88% | Volatility(W/M) | 4.31% 3.41% | Perf 5Y | 38.82% |
| Dividend TTM | - | EV/Sales | 1.25 | Sales Y/Y TTM | 15.93% | Oper. Margin | 6.7% | ATR (14) | 0.37 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.05 | EPS Q/Q | 1141.38% | Profit Margin | -0.26% | RSI (14) | 45.72 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.05 | Sales Q/Q | 18.31% | SMA20 | 0.67% ($9.13) | Beta | 0.16 | Target Price | $12 |
| Payout | - | Debt/Eq | 0.37 | Earnings | 2026/11/3 | SMA50 | -6.6% ($9.84) | Rel Volume | 1.15 | Prev Close | $9.24 |
| Employees | 2500 | LT Debt/Eq | 0.31 | EPS/Sales Surpr. | -19.68% 9.91% | SMA200 | 1.38% ($9.06) | Avg Volume(3M) | 0.51M | Price | $9.19 |
| IPO | 2021/3/4 | Option/Short | Yes/Yes | Trades | 3390 | Volume | 593,067 | Change | -0.54% |
🏥 InnovAge Holding Corp. (INNV) is a healthcare company that operates the Program of All-Inclusive Care for the Elderly (PACE), a U.S. integrated care program for seniors. It provides medical, long-term care, and daily living support under one roof for elderly and vulnerable individuals who qualify for both Medicare and Medicaid, and has established itself as one of the largest for-profit PACE operators in the United States.
Over the past 1 year, roughly in the middle
27% below its 1-year high.
Traded about as much as usual. That is 115% of its average volume.
Next earnings report: November 3
3 days to go.
INNV keeps an operating profit but posts a net loss
Of every $100 in sales, $6.70 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +2301.7% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $127. Peers typically go for $89.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 5 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +38.8%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 13.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #31 of 48 in the industry
Based on market cap of $1B.
FAQ
What kind of company is INNV?
INNV belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of INNV?
The market cap of INNV is approximately $1.3B, ranking 2,410 within its sector.
What is the 52-week high and low for INNV?
INNV has recorded a 52-week high of $12.64 and a low of $3.93.